Physiological insulin resistance and hyperinsulinemia occurs at the onset of puberty, and is thought to contribute to peri-pubertal growth and development. However, in contrast to IGF-1, little is known about how insulin affects the hypothalamic-pituitary-ovarian (HPO) axis in peri-pubertal girls. Insulin has mitogenic and metabolic activity through splice-variant isoform receptors IR-A and IR-B, respectively. We hypothesize that insulin signaling in HPO tissues contributes to the initiation of puberty, and sought to determine whether IR isoform expression is differentially regulated during puberty.

We evaluated female, FVB/NJ mice: pre-pubertal, 3-4 week old mice (n=4) and peri-pubertal mice (n=7) identified within 24 hours of vaginal opening, an external marker of puberty. IR-A, IR-B, IGF-1R were quantified using a qRT-PCR assay previously validated for receptor comparison. Receptor expression was analyzed by Student’s t-test after log transformation.

IR-A was the predominant IR isoform in the prepubertal hypothalamus, pituitary, and ovary, in a 20:1, 10:1, and 2:1 ratio with IR-B, respectively (p<0.05, all). At puberty, IR-A did not change in the hypothalamus, whereas IR-A increased by 3.6-fold (p=0.059) in the pituitary. IR-B remained largely unchanged during puberty in both the hypothalamus and pituitary (p=NS, respectively). Interestingly, in the peripubertal ovary which has active folliculogenesis and steroid hormone synthesis, both IR-A and IR-B decreased by 33% and 68%, respectively (p<0.03). As expected, IGF-1R levels were higher than IR isoforms in HPO tissues, at both developmental stages. Similar to mitogenic IR-A, IGF-1R increased in the pituitary (p<0.059) during puberty.

An increase in pituitary IR-A expression at the onset of puberty suggests a role for insulin signaling in regulating pituitary hormone production related to puberty. Obesity, a known risk factor for early puberty development in girls, may alter normal insulin signaling in the HPO axis.

Disclosure

F. Saleh: None. H.S. Taylor: None. C. Flannery: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.